Thomas Westrick, the CEO of Patient Care Solutions at GE HealthCare Technologies Inc (GEHC, Financial), sold 2,750 shares of the company on August 7, 2024. The transaction was reported in a recent SEC Filing. Following this sale, the insider now owns 17,509 shares of GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc operates in the healthcare sector, providing medical technologies and services. The company's offerings include medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies. These innovative solutions are designed to help healthcare professionals predict, diagnose, inform, and treat disease, so patients can live their best lives.
Over the past year, Thomas Westrick has sold a total of 2,750 shares and has not purchased any shares. The insider transaction history for GE HealthCare Technologies Inc shows a trend with 1 insider buy and 3 insider sells over the past year.
On the day of the latest transaction by the insider, shares of GE HealthCare Technologies Inc were trading at $80.78. This valuation gives the company a market cap of approximately $36.21 billion. The price-earnings ratio of the stock stands at 23.71, slightly lower than the industry median of 23.8 but higher than the company’s historical median.
For more detailed information on the valuation metrics of GE HealthCare Technologies Inc, such as price-sales ratio, price-book ratio, and price-to-free cash flow, interested investors may refer to the GF Value for a comprehensive analysis.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
